Skip to main content

Table 1 The demographic and clinical characteristics of the study participants

From: Variation in IL-21-secreting circulating follicular helper T cells in Kawasaki disease

Parameters Kawasaki disease Controls (n = 20)
Acute phase (n = 24) Remission phase (n = 19)
Age, year 2.75 (0.6–5) NA 2.38 (0.9–4.5)
Sex, Female/Male 11/14 NA 8/12
CRP, mg/L 76.25 (20–151)#, 2.76 (0.8–5.28) 2.35 (0.7–3.28)
ESR, mm/h 51.37 (11–98)# 53.67 (9–76)# 7 (3–11)
IgG, g/L 6.295 (1.82–16.1)# NA 10.22 (6.08–14.37)
IgA, g/L 1.715 (0.91–2.92) NA 1.91 (0.71–3.1)
IgM, g/L 0.99 (0.19–1.77) NA 1.035 (0.69–1.93)
WBC, 109/L 14.31 (5.89–35)#, 8.729 (4.82–13.79) 7.735 (5.31–10.03)
Neutrophils, 109/L 10.14 (2.52–33.69)#, 2.98 (1.98–5.09) 2.58 (2.06–4.69)
Lymphocytes, 109/L 2.915 (0.88–8.82) 3.736 (1.92–6.75) 4.085 (1.01–5.28)
  1. Data shown are median (range) or number of cases. CRP C-reactive protein, ESR erythrocyte sedimentation rate, Ig immunoglobulin, WBC white blood cell counts, NA not available. #P < 0.05 vs. the controls. *P < 0.05 vs. remission phase